Cargando…

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?

Detalles Bibliográficos
Autor principal:	Horst, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237777/ https://www.ncbi.nlm.nih.gov/pubmed/34181167 http://dx.doi.org/10.1007/s10620-021-07106-y

Ejemplares similares

IBD in the Time of COVID19
por: Moss, Alan, et al.
Publicado: (2020)

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic. Authors' reply
por: King, Dominic Stephen, et al.
Publicado: (2020)

Children with Severe Malnutrition: Can Those at Highest Risk of Death Be Identified with the WHO Protocol?
por: Maitland, Kathryn, et al.
Publicado: (2006)

WHO statement – “Older people are at highest risk from COVID-19”: Should the hypothesis be corroborated or rejected?
por: Ningthoujam, Ramananda, et al.
Publicado: (2020)

IBD in the elderly - beware of pitfalls!
por: Sharip, Mohmmed T., et al.
Publicado: (2023)

Prevention of COVID-19 in patients with IBD
por: Segal, Jonathan P, et al.
Publicado: (2020)

Diet and Nutrition in IBD—Progress and Gaps
por: Raman, Maitreyi, et al.
Publicado: (2019)

Addressing Mental Health in Persons with IBD
por: Bernstein, Charles N
Publicado: (2018)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
por: Barnes, Alex, et al.
Publicado: (2022)

Epidemiology and Natural History of IBD in the Paediatric Age
por: Guariso, Graziella, et al.
Publicado: (2014)

Personalized management of IBD; is there any practical approach?
por: Norouzinia, Mohsen, et al.
Publicado: (2015)

“Diet in the Etiopathogenesis of IBD: Is There A Culinary Culprit?”
por: Issokson, Kelly
Publicado: (2020)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

COVID-19 Serologic Testing Among the Highest Risk Healthcare Workers
por: Gandhi, Snehal, et al.
Publicado: (2021)

Which cancer type has the highest risk of COVID-19 infection?
por: Cai, Changjing, et al.
Publicado: (2020)

Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect
por: Occhipinti, Vincenzo, et al.
Publicado: (2021)

Are Patient Self-reported Healthcare Utilization Data Reliable in Persons With IBD?
por: El-Matary, Wael
Publicado: (2021)

Impact of Different Nutrition Strategies on Patients with Inflammatory Bowel Disease (IBD)
por: Papadimitriou, Konstantinos, et al.
Publicado: (2023)

Managing IBD in the COVID-19 era
por: Scalzo, Nicholas, et al.
Publicado: (2023)

JAK Inhibitors: Back to Small Molecules for the Treatment of IBD
por: Panés, Julian, et al.
Publicado: (2020)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Using IBD-REFER: A Substitute for Clinical Judgement?
por: Dueker, Jeffrey M, et al.
Publicado: (2020)

COVID-19—from mucosal immunology to IBD patients
por: Weidinger, Carl, et al.
Publicado: (2021)

Psychological reaction to Covid-19 of Italian patients with IBD
por: Savarese, Mariarosaria, et al.
Publicado: (2021)

Prevention of COVID-19 in patients with IBD – Authors' reply
por: Ding, Nik Sheng, et al.
Publicado: (2020)

Excessive anxiety in IBD patients is unnecessary for COVID-19
por: Wang, Hong-Gang, et al.
Publicado: (2020)

Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)

Increased risk of psychiatric sequelae of COVID-19 is highest early in the clinical course
por: Coleman, Ben, et al.
Publicado: (2021)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Personalised medicine in IBD: don’t dispose of the sledgehammer just yet
por: Kumar, Aditi, et al.
Publicado: (2022)

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
por: Caminati, Marco, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Absence of detrusor muscle in TUR-BT specimen – can we predict who is at highest risk?
por: Volz, Yannic, et al.
Publicado: (2023)

293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19
por: Chaftari, Anne-Marie, et al.
Publicado: (2021)

Genetic Risk of Severe Covid-19
por: Kaser, Arthur
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ge7pk8k4n5qjf4u161aku7bvb2